After ascites improves or resolves on standard therapy, what criteria do you use to continue carvedilol long term versus de-escalate/stop it, and which clinical or noninvasive surrogates (beyond symptoms alone) are most persuasive to you?

Khajuria, Rahul MD, DM1,*; Jindal, Ankur MD, DM1,*; Sharma, Manoj Kumar MD, DM1; Arora, Vinod MD, DM1; Vyas, Ashish Kumar PhD2; Kumar, Guresh PhD3; Sarin, Shiv Kumar MD, DM1. Efficacy and Safety of Carvedilol in Cirrhosis Patients With New-Onset Uncomplicated Ascites Without High-Risk Esophageal Varices (CARVE-AS Trial). The American Journal of Gastroenterology 121(6):p 1372-1381, June 2026.